Goldman Sachs is one of the biggest investment banker “book runners” for IPOs -- where banks are paid many millions of ...

Goldman Sachs initiated coverage on ResMed Inc (NYSE:RMD) with a "Buy" rating and a price target of A$48.9, driven by strong growth prospects in its continuous airway pressure (CPAP) therapy segment.

Analysts from Wolfe Research, Goldman Sachs, and HSBC downgrade AMD, citing weak AI chip demand and rising competition. Could ...

DigniFi Strengthens Leadership Team with New Board Members, CFO; Welcomes Scott Roberts, Rachel Richards, Kenny DellaPorta, ...

We recently published a list of 10 Best Bank Stocks to Buy in 2025. In this article, we are going to take a look at where ...

In a remarkable display of market confidence, Goldman Sachs Group Inc (NYSE:GS). shares have surged to an all-time high, ...

The bank, which owns a minority stake in Viva Wallet, can take over the company in June if its valuation falls before a ...

Toro confidentially files for US IPO with Goldman Sachs, seeking $5 billion valuation, despite past setbacks, aiming for ...

Multiple traders were already signed onto the program at the time of launch, according to Dub. Their roster includes Andrew ...

Investment banking giant Goldman Sachs has deemed Tesla a leader in self-driving — but thinks the payoff is still far away.

Just a day after the Goldman Sachs CEO said that his company's deal to service Apple Card customers may end early, two banks ...

That is because many of these technologies are evolving at such a rapid pace that the enterprise community has not fully ...